Camire, Rodney M

AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes

Hui, D. J., Edmonson, S. C., Podsakoff, G. M., Pien, G. C., Ivanciu, L., Camire, R. M., Ertl, H., Mingozzi, F., High, K. A., & Basner-Tschakarjan, E. (2015) · Molecular Therapy - Methods & Clinical Development

Virus-based gene therapy researchImmunotherapy and Immune Responses

Cited by 84

Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A

Nguyen, G. N., George, L. A., Siner, J. I., Davidson, R. J., Zander, C. B., Zheng, X. L., Arruda, V. R., Camire, R. M., & Sabatino, D. E. (2017) · Journal of Thrombosis and Haemostasis

Hemophilia Treatment and ResearchVirus-based gene therapy research

Cited by 50

Hyperactivity of factor IX Padua (R338L) depends on factor VIIIa cofactor activity

Samelson-Jones, B. J., Finn, J. D., George, L. A., Camire, R. M., & Arruda, V. R. (2019) · JCI Insight

Hemophilia Treatment and ResearchVirus-based gene therapy research

Cited by 44

A rapid pro-hemostatic approach to overcome direct oral anticoagulants

Thalji, N. K., Ivanciu, L., Davidson, R., Gimotty, P. A., Krishnaswamy, S., & Camire, R. M. (2016) · Nature Medicine

Blood Coagulation and Thrombosis MechanismsHemophilia Treatment and Research

Cited by 43

Evolutionary Insights Into Coagulation Factor IX Padua and Other High-Specific-Activity Variants

Samelson-Jones, B. J., Finn, J. D., Raffini, L. J., Merricks, E. P., Camire, R. M., Nichols, T. C., & Arruda, V. R. (2021) · Blood Advances

Hemophilia Treatment and ResearchBlood Coagulation and Thrombosis Mechanisms

Cited by 31